Xenbase is undergoing scheduled maintenance Wednesday, June 14 and Thursday, June 15, 2023. Xenbase will be unavailable on those days.

Click on this message to dismiss it.
Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-41008
Science 2009 Dec 18;3265960:1698-701. doi: 10.1126/science.1182372.
Show Gene links Show Anatomy links

The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair.

Knipscheer P , Räschle M , Smogorzewska A , Enoiu M , Ho TV , Schärer OD , Elledge SJ , Walter JC .


Abstract
Fanconi anemia is a human cancer predisposition syndrome caused by mutations in 13 Fanc genes. The disorder is characterized by genomic instability and cellular hypersensitivity to chemicals that generate DNA interstrand cross-links (ICLs). A central event in the activation of the Fanconi anemia pathway is the mono-ubiquitylation of the FANCI-FANCD2 complex, but how this complex confers ICL resistance remains enigmatic. Using a cell-free system, we showed that FANCI-FANCD2 is required for replication-coupled ICL repair in S phase. Removal of FANCD2 from extracts inhibits both nucleolytic incisions near the ICL and translesion DNA synthesis past the lesion. Reversal of these defects requires ubiquitylated FANCI-FANCD2. Our results show that multiple steps of the essential S-phase ICL repair mechanism fail when the Fanconi anemia pathway is compromised.

PubMed ID: 19965384
PMC ID: PMC2909596
Article link: Science
Grant support: [+]

Species referenced: Xenopus laevis
Genes referenced: fancd2 fanci

References [+] :
Akkari, The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. 2001, Pubmed